XML 78 R61.htm IDEA: XBRL DOCUMENT v3.10.0.1
Recent Accounting Guidance Revenue ASU - Income Statement Impact (Details) - USD ($)
$ in Millions
1 Months Ended 2 Months Ended 3 Months Ended 4 Months Ended 8 Months Ended 12 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2017
Aug. 31, 2017
Dec. 31, 2018
Dec. 31, 2016
Effect of Adoption of ASU 2017-07 [Member]                          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                          
Cost of Goods Sold                   $ 75 $ (153)   $ (18)
Sundry income (expense) - net                   134 (279)   (40)
Research and Development Expense                   19 (42)   (6)
Selling, General and Administrative Expense                   40 (84)   (16)
Effect of Adoption of ASU 2014-09 [Member]                          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                          
Net Sales                       $ (69)  
Sundry income (expense) - net                       71  
Loss from continuing operations before income taxes                       2  
Provision for (benefit from) income taxes on continuing operations                       0  
Loss from continuing operations after income taxes                       2  
Balance without Adoption of ASU 2014-09 [Member]                          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                          
Net Sales                       26,210  
Sundry income (expense) - net                       614  
Loss from continuing operations before income taxes                       (4,791)  
Provision for (benefit from) income taxes on continuing operations                       220  
Loss from continuing operations after income taxes                       (5,011)  
Previously Reported [Member]                          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                          
Cost of Goods Sold                   6,165 10,205   13,955
Sundry income (expense) - net                   90 166   707
Research and Development Expense                   473 1,064   1,502
Selling, General and Administrative Expense                   1,101 3,306   4,143
Successor [Member]                          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                          
Cost of Goods Sold $ 1,531 [1]   $ 3,980 [1] $ 3,686 [1] $ 5,669 [1] $ 4,847 [1] $ 4,709 [1]     6,240   18,182  
Net Sales 1,735   5,741 5,294 8,545 6,699 5,318     7,053   26,279  
Sundry income (expense) - net                   224   543  
Loss from continuing operations before income taxes                   (1,586)   (4,793)  
Provision for (benefit from) income taxes on continuing operations                   (2,673)   220  
Loss from continuing operations after income taxes $ (275)   $ (351) [2],[3] $ (4,960) [3],[4] $ 514 [3] $ (216) [3] $ 1,362 [3]     1,087   (5,013)  
Research and Development Expense                   492   1,524  
Selling, General and Administrative Expense                   $ 1,141   $ 3,853  
Predecessor [Member]                          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                          
Cost of Goods Sold   $ 1,937           $ 3,963 $ 4,152   10,052   13,937
Net Sales   2,991           6,971 7,319   17,281   23,209
Sundry income (expense) - net                     (113)   667
Loss from continuing operations before income taxes                     1,791   2,723
Provision for (benefit from) income taxes on continuing operations                     149   641
Loss from continuing operations after income taxes   $ (258)           $ 722 $ 1,178 [5],[6]   1,642   2,082
Research and Development Expense                     1,022   1,496
Selling, General and Administrative Expense                     $ 3,222   $ 4,127
[1] Includes charges of $(360) million and $(1,109) million, $(703) million, $(682) million, $(109) million, and $(134) million during the period September 1 - September 30, 2017, fourth quarter 2017, first quarter 2018, second quarter 2018, third quarter 2018, and fourth quarter 2018, respectively, related to the amortization of inventory step-up as a result of the Merger and the acquisition of the H&N Business. See Note 3 for additional information.
[2] Includes a loss on early extinguishment of debt of $(81) million in the fourth quarter 2018 related to the retirement of some of the company's notes payable. See Note 15 for additional information.
[3] Includes a tax benefit of $2,262 million in the fourth quarter 2017 related to The Act and a benefit related to an internal entity restructuring associated with the Intended Business Separations. Includes tax (charges) benefits of $(102) million, $(7) million, $46 million, and $(167) million in the first quarter 2018, second quarter 2018, third quarter 2018, and fourth quarter 2018, respectively, related to The Act. See Note 9 for additional information.
[4] Includes a tax charge of $(75) million in the third quarter 2018 related to the establishment of a full valuation allowance against the net deferred tax asset position of a legal entity in Brazil. See Note 9 for additional information.
[5] First quarter 2017 included a gain of $162 million recorded in sundry income - net associated with the sale of the company's global food safety diagnostic business. See Note 4 for additional information.
[6] First quarter 2017 included a tax benefit of $53 million, as well as a $47 million benefit on associated accrued interest reversals (recorded in sundry income (expense) - net), related to a reduction in the company’s unrecognized tax benefits due to the closure of various tax statutes of limitations.